Norio Yasui

1.2k total citations
37 papers, 963 citations indexed

About

Norio Yasui is a scholar working on Psychiatry and Mental health, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Norio Yasui has authored 37 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 8 papers in Pharmacology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Norio Yasui's work include Schizophrenia research and treatment (17 papers), Bipolar Disorder and Treatment (9 papers) and Epilepsy research and treatment (9 papers). Norio Yasui is often cited by papers focused on Schizophrenia research and treatment (17 papers), Bipolar Disorder and Treatment (9 papers) and Epilepsy research and treatment (9 papers). Norio Yasui collaborates with scholars based in Japan, United States and Sweden. Norio Yasui's co-authors include Sunao Kaneko, Koichi Otani, Tadashi Ohkubo, Kazunobu Sugawara, John A. Katzenellenbogen, Kazuo Mihara, Tsuyoshi Kondo, Akihito Suzuki, Hanako Furukori and Takako Osanai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.

In The Last Decade

Norio Yasui

35 papers receiving 940 citations

Peers

Norio Yasui
Andrew K.L. Goey United States
Dewei Shang China
Philip Chaikin United States
Mie Kristensen Denmark
Bo‐Hyung Kim South Korea
Emil Samara United States
Andrew Acheampong United States
Vincenzo Pucci Italy
Guofei Li China
E. Dolfini Italy
Andrew K.L. Goey United States
Norio Yasui
Citations per year, relative to Norio Yasui Norio Yasui (= 1×) peers Andrew K.L. Goey

Countries citing papers authored by Norio Yasui

Since Specialization
Citations

This map shows the geographic impact of Norio Yasui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norio Yasui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norio Yasui more than expected).

Fields of papers citing papers by Norio Yasui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norio Yasui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norio Yasui. The network helps show where Norio Yasui may publish in the future.

Co-authorship network of co-authors of Norio Yasui

This figure shows the co-authorship network connecting the top 25 collaborators of Norio Yasui. A scholar is included among the top collaborators of Norio Yasui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norio Yasui. Norio Yasui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akça, Ümmüşen Kaya, Yujun Zhang, Norio Yasui, et al.. (2025). PET Imaging of System A Amino Acid Transport Detects Early Response to Immune Checkpoint Inhibitor Therapy in a Syngeneic Mouse Model.. PubMed. 66(12). 1908–1913.
2.
Kim, Sung Hoon, Kelli Lauderdale, Andrew Lapato, et al.. (2019). Analogues of ERβ ligand chloroindazole exert immunomodulatory and remyelinating effects in a mouse model of multiple sclerosis. Scientific Reports. 9(1). 503–503. 18 indexed citations
3.
Xing, Hang, Li Tang, Xujuan Yang, et al.. (2013). Selective delivery of an anticancer drug with aptamer-functionalized liposomes to breast cancer cells in vitro and in vivo. Journal of Materials Chemistry B. 1(39). 5288–5288. 161 indexed citations
4.
5.
Mihara, Kazuo, Akihito Suzuki, Tsuyoshi Kondo, et al.. (2000). Effect of a Genetic Polymorphism of CYP1A2 Inducibility on the Steady State Plasma Concentrations of Haloperidol and Reduced Haloperidol in Japanese Patients With Schizophrenia. Therapeutic Drug Monitoring. 22(3). 245–249. 13 indexed citations
6.
Mihara, Kazuo, Tsuyoshi Kondo, Akihito Suzuki, et al.. (2000). Prolactin response to nemonapride, a selective antagonist for D 2 like dopamine receptors, in schizophrenic patients in relation to Taq 1A polymorphism of DRD2 gene. Psychopharmacology. 149(3). 246–250. 38 indexed citations
7.
Furukori, Hanako, Tsuyoshi Kondo, Norio Yasui, et al.. (1999). Effects of itraconazole on the steady-state plasma concentrations of bromperidol and reduced bromperidol in schizophrenic patients. Psychopharmacology. 145(2). 189–192. 11 indexed citations
8.
Otani, Koichi, et al.. (1999). Characteristics and Risk Factors of Acute Dystonia in Schizophrenic Patients Treated With Nemonapride, a Selective Dopamine Antagonist. Journal of Clinical Psychopharmacology. 19(1). 45–50. 7 indexed citations
9.
10.
Eap, Chin B., et al.. (1999). Effects of Carbamazepine Coadministration on Plasma Concentrations of the Enantiomers of Mianserin and of its Metabolites. Therapeutic Drug Monitoring. 21(2). 166–170. 12 indexed citations
11.
Yasui, Norio, et al.. (1998). Correlation between steady-state plasma concentrations (Css) of bromperidol and haloperidol. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 22(3). 485–492. 3 indexed citations
12.
Yasui, Norio, Tsuyoshi Kondo, Koichi Otani, et al.. (1998). Prolactin Response to Bromperidol Treatment in Schizophrenic Patients. Pharmacology & Toxicology. 82(3). 153–156. 18 indexed citations
13.
Yasui, Norio, Tsuyoshi Kondo, Koichi Otani, et al.. (1998). Effect of itraconazole on the single oral dose pharmacokinetics and pharmacodynamics of alprazolam. Psychopharmacology. 139(3). 269–273. 51 indexed citations
14.
Yasui, Norio, Koichi Otani, Tadashi Ohkubo, et al.. (1997). Single-Dose Pharmacokinetics and Pharmacodynamics of Oral Triazolam in Relation to Cytochrome P4502C19 (CYP2C19) Activity. Therapeutic Drug Monitoring. 19(4). 371–374. 7 indexed citations
15.
16.
Suzuki, Akihito, Koichi Otani, Kazuo Mihara, et al.. (1997). Effects of the CYP2D6 genotype on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese schizophrenic patients. Pharmacogenetics. 7(5). 415–418. 57 indexed citations
17.
Mihara, Kazuo, K. Otani, Akihito Suzuki, et al.. (1997). Relationship between the CYP2D6 genotype and the steady-state plasma concentrations of trazodone and its active metabolite m -chlorophenylpiperazine. Psychopharmacology. 133(1). 95–98. 30 indexed citations
18.
Otani, Koichi, Masayuki Ishida, Norio Yasui, et al.. (1997). No Effect of the Anticholinergic Drugs Trihexyphenidyl and Biperiden on the Plasma Concentrations of Bromperidol and Its Reduced Metabolite. Therapeutic Drug Monitoring. 19(2). 165–168. 10 indexed citations
19.
Mihara, Kazuo, Koichi Otani, Masayuki Ishida, et al.. (1997). Increases in Plasma Concentration of m-Chlorophenylpiperazine, but not Trazodone, with Low-Dose Haloperidol. Therapeutic Drug Monitoring. 19(1). 43–45. 11 indexed citations
20.
Ishida, Masayuki, et al.. (1996). No interaction between desipramine and bromperidol. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 20(7). 1265–1271. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew K.L. Goey Breakdown of academic impact, for papers by Dewei Shang Breakdown of academic impact, for papers by Philip Chaikin Breakdown of academic impact, for papers by Mie Kristensen Breakdown of academic impact, for papers by Bo‐Hyung Kim Breakdown of academic impact, for papers by Emil Samara Breakdown of academic impact, for papers by Andrew Acheampong Breakdown of academic impact, for papers by Vincenzo Pucci Breakdown of academic impact, for papers by Guofei Li Breakdown of academic impact, for papers by E. Dolfini
Rankless by CCL
2026